Trial intelligence / Profile preview

Potassium Citrate in Postmenopausal Osteopenia

NCT00357331Phase 4Completed

Sponsor
Weill Cornell Medicine
Start
Aug 2006
Primary completion
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of potassium citrate in osteopenia, sponsored by Weill Cornell Medicine. Started Aug 2006; status: completed.

02

Drugs

potassium citrate
03

Conditions

osteopenia

Beyond the preview

Go deeper on NCT00357331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00357331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call